Form 8-K - Current report:
SEC Accession No. 0001213900-25-055656
Filing Date
2025-06-18
Accepted
2025-06-18 16:15:25
Documents
14
Period of Report
2025-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246169-8k_synergy.htm   iXBRL 8-K 49061
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION ea024616901ex3-1_synergy.htm EX-3.1 7331
3 AMENDMENT TO SYNERGY CHC CORP. 2024 EQUITY INCENTIVE PLAN ea024616901ex10-1_synergy.htm EX-10.1 5040
  Complete submission text file 0001213900-25-055656.txt   233023

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snyr-20250618.xsd EX-101.SCH 3020
5 XBRL LABEL FILE snyr-20250618_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE snyr-20250618_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0246169-8k_synergy_htm.xml XML 3675
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42374 | Film No.: 251057147
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)